MedTrace Logo

Validation of the German Version of the Injustice Experience Questionnaire

NCT02552719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2021-02-17

No results posted yet for this study

Summary

Purpose of the study is the validation of the German version of the Injustice Experience Questionnaire.

Pretest: Participants were informed about the aims of the study and fill in a consent form. They filled in a paper version of the German translation of the Injustice Experience Questionnaire. In a structured interview patients were asked if there were any items difficult to understand, unacceptable or offending them. Subsequently they had to answer questions about the content and meaning of the IEQ-items.

Validation Study: Participants were informed about the aims of the study and filled in a consent form. By e-mail they received an access link to the online survey. The questionnaires of the survey could be filled in at home. The survey could be interrupted and terminated later. About 20 minutes were needed to answer the 80 questions of the survey. All data was saved anonymously during the survey.

Conditions

  • Validation Studies

Sponsors & Collaborators

  • Kantonsspital Baden

    collaborator OTHER

  • Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen

    collaborator OTHER

  • Cantonal Hospital of St. Gallen

    collaborator OTHER

  • University Hospital, Saarland

    collaborator OTHER

  • Swiss Paraplegic Research, Nottwil

    collaborator NETWORK

  • University of Zurich

    lead OTHER

Principal Investigators

  • Dominik Ettlin, MD, DMD · University of Zurich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-01
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02552719 on ClinicalTrials.gov